Understanding the Shift in Migraine Therapies Over Time
From the early disorganized approach to the now CGRP targeting monocled antibodies, Piero Barbanti, an associate professor of neurology and president of the Italian Headache Sufferers Association, takes us through the eras of treating migraines.
